INS, 35-64 Antibody from MYBIOSOURCE INC.

Search, find, compare suppliers for anti-INS, 35-64 antibody, protein, ELISA kits.

Edit 
Antigenic SpecificityINS, 35-64
Clone[396CT20.4.4]
Host SpeciesMouse
Reactive Specieshuman
IsotypeIgM
Formatascites
Size0.1 mL
Concentrationn/a
ApplicationsWestern Blot (WB), ELISA (EIA)
Reviews / RatingsIf you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY.
DescriptionThis INS antibody is generated from mice immunized with a KLH conjugated synthetic peptide between 35-64 amino acids from human INS. After removal of the precursor signal peptide, proinsulinis post-translationally cleaved into three peptides: the B chainand A chain peptides, which are covalently linked via two disulfidebonds to form insulin, and C-peptide. Binding of insulin to theinsulin receptor (INSR) stimulates glucose uptake. A multitude ofmutant alleles with phenotypic effects have been identified. Thereis a read-through gene, INS-IGF2, which overlaps with this gene atthe 5' region and with the IGF2 gene at the 3' region. Alternativesplicing results in multiple transcript variants. [provided byRefSe
Immunogenn/a
Other Names[Insulin; Insulin B chain; Insulin A chain; INS]
Gene, Accession #[INS], Gene ID: 3630, NCBI: NP_000198.1, UniProt: P01308
Catalog #MBS9200500
Price$370
Order / More InfoINS, 35-64 Antibody from MYBIOSOURCE INC.
Product Specific ReferencesHinks, A., et al. Ann. Rheum. Dis. 69(12):2169-2172(2010) Breuer, T.G., et al. Eur. J. Endocrinol. 163(4):551-558(2010) Andersen, M.K., et al. Diabetes Care 33(9):2062-2064(2010) Ferron, M., et al. Cell 142(2):296-308(2010) Authier, F., et al. J. Biol. Chem. 277(11):9437-9446(2002)
MYBIOSOURCE INC.
MYBIOSOURCE INC.
MYBIOSOURCE INC.
P.O. Box 153308
San Diego CA 92195-3308
P: 1.858.633.0165
P: 1.888.MBS.0165 (1.888.627.0165) (US & Canada)
F: 1.858.633.0166

sales@mybiosource.com

http://www.MyBioSource.com

Profile of MYBIOSOURCE INC.
Return to Antibodies

© 1980 - 2024 Linscott's Directory, Linscott's USA. All rights reserved.